All seven director nominees
elected
Executive changes support Company's
growth
LEAMINGTON, ON, Nov. 15, 2019 /PRNewswire/ - Aphria Inc.
("Aphria" or the "Company") (TSX: APHA and NYSE:
APHA) today announced that all seven of the nominees listed in
the Company's management information circular dated October 4, 2019 were elected as directors of the
Company at the Company's Annual Meeting of Shareholders held
in Toronto, Ontario on
November 14, 2019.
The following table provides detailed results of matters which
were considered and voted upon:
Matters Voted Upon
at the Meeting
|
Votes in
Favour
|
%
|
Votes
Withheld
|
%
|
1. Election of
Directors
|
|
|
|
|
Irwin D.
Simon
|
27,054,172
|
95.54
|
1,263,861
|
4.46
|
John M.
Herhalt
|
27,268,609
|
96.29
|
1,049,424
|
3.71
|
Jodi Butts
|
27,149,031
|
95.87
|
1,169,002
|
4.13
|
David
Hopkinson
|
27,238,224
|
96.19
|
1,079,809
|
3.81
|
Tom Looney
|
24,774,168
|
87.49
|
3,543,865
|
12.51
|
Renah
Persofsky
|
27,030,187
|
95.45
|
1,287,845
|
4.55
|
Walter Robb
|
27,262,772
|
96.27
|
1,055,260
|
3.73
|
2.
Re-appointment of Auditors –PricewaterhouseCoopers LLP
|
87,958,602
|
97.31
|
2,427,180
|
2.69
|
In addition to the re-election of Mr. Simon, Mr. Herhalt, Mr.
Robb, Ms. Persofsky, Mr. Looney,
and Mr. Hopkinson, shareholders elected the following new
director:
Jodi Butts
Ms. Butts is a lawyer, entrepreneur, and a seasoned executive
with a strong track record in driving positive change and growth
within leading organizations. Previously, Ms. Butts served as Chief
Executive Officer of Rise Asset Development and Senior
Vice‐President of Operations and Redevelopment at Mount Sinai
Hospital. Currently, Ms. Butts serves as an independent member of
the Board of Directors of Canada Goose Inc.; a member of the Board
of Directors of Dot Health; a member of the Board of Governors and
Audit Committee of the University of
Windsor; and a member of the Walrus Foundation Board of
Directors and Risk Management Committee. She also holds several
Board Advisory roles including with Bayshore Home Healthcare and
the World Health Innovation Network at the University of
Windsor.
Executive Appointments and Promotions
The Company also announced several appointments and promotions
to the Company's executive leadership team subject to the issuance
of their security clearances by Health Canada:
Denise
Faltischek joins as Chief Strategy Officer (CSO)
with extensive consumer-packaged goods experience and expertise
leading over 50 acquisitions. As CSO, Ms. Faltischek will work with
Mr. Simon on the Company's global strategy as the Company scales
its operations internationally and explores opportunities in
the United States. Ms. Faltischek
will also oversee Aphria's medical and international business
segments, as well as quality function.
Tamara Macgregor,
previously Vice President, Communications and Public Affairs, is
promoted to Chief Corporate Affairs Officer. Ms. Macgregor
will lead an integrated corporate affairs team responsible for the
Company's global corporate communications, brand PR, public
affairs, and corporate social responsibility and sustainability
efforts.
Megan
McCrae, previously Vice President of Marketing, is
promoted to Chief Marketing Officer. In this role, Ms. McCrae will
lead global marketing efforts, including brand, portfolio,
innovation and marketing strategy across the medical, recreational,
and wellness lines of business.
Bernie Yeung joins as
Vice President, Sales and Channel Strategy. Mr. Yeung's expertise
in the cannabis, consumer packaged goods and alcohol industries
will help further Aphria's growth as it continues to grow its
competitive position in both the adult-use and medical markets.
Responsible for managing all recreational, retail and medical
sales, Mr. Yeung will drive new and existing product distribution
coast to coast.
"We are excited to welcome Bernie and Denise to the Aphria
team and very pleased to announce the well-deserved promotions of
Tamara and Megan," said Irwin D.
Simon. "We have assembled a strong team of leaders,
including our existing executives who made significant
contributions to help transform Aphria into a leading global
cannabis company, combined with new key hires, that together will
provide a robust depth of experience in the key areas of
operations, strategy, sales and marketing, IT and human resources
to support our long-term growth opportunities domestically and
internationally."
We Have A Good Thing Growing
About Aphria Inc.
Aphria Inc. is a leading global
cannabis company driven by an unrelenting commitment to our people,
the planet, product quality and innovation. Headquartered in
Leamington, Ontario – the
greenhouse capital of Canada –
Aphria Inc. has been setting the standard for the low-cost
production of high-quality cannabis at scale, grown in the most
natural conditions possible. Focusing on untapped opportunities and
backed by the latest technologies, Aphria Inc. is committed to
bringing breakthrough innovation to the global cannabis market. The
Company's portfolio of brands is grounded in expertly-researched
consumer insights designed to meet the needs of every consumer
segment. Rooted in our founders' multi-generational expertise in
commercial agriculture, Aphria Inc. drives sustainable long-term
shareholder value through a diversified approach to innovation,
strategic partnerships and global expansion, with a presence in
more than 10 countries across 5 continents.
For more information, visit: aphriainc.com
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain
information in this news release constitutes forward-looking
statements under applicable securities laws. Any statements that
are contained in this news release that are not statements of
historical fact may be deemed to be forward-looking statements.
Forward looking statements are often identified by terms such as
"may", "should", "anticipate", "expect", "potential", "believe",
"intend" or the negative of these terms and similar expressions.
Forward-looking statements in this news release include, but are
not limited to, the expected success of our leadership team.
Forward-looking statements necessarily involve known and unknown
risks, including, without limitation, risks associated with general
economic conditions; adverse industry events; marketing costs; loss
of markets; future legislative and regulatory developments
involving cannabis; inability to access sufficient capital from
internal and external sources, and/or inability to access
sufficient capital on favourable terms; the cannabis industry in
Canada generally, income tax and
regulatory matters; the ability of Aphria Inc. to implement its
business strategies; competition; crop failure; currency and
interest rate fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive
and should carefully review the various risks and uncertainties
identified in the Company's filings on SEDAR and EDGAR. Readers are
further cautioned not to place undue reliance on forward-looking
statements as there can be no assurance that the plans, intentions
or expectations upon which they are placed will occur. Such
information, although considered reasonable by management at the
time of preparation, may prove to be incorrect and actual results
may differ materially from those anticipated.
The forward-looking statements included in this news release are
made as of the date of this news release and the Company does not
undertake an obligation to publicly update such forward-looking
statements to reflect new information, subsequent events or
otherwise unless required by applicable securities laws.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aphria-inc-announces-election-of-board-of-directors-and-executive-appointments-and-promotions-300959130.html
SOURCE Aphria Inc.